Ginger patch takes on acne: a natural approach?
NCT ID NCT06787222
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 2 times
Summary
This study tests a ginger extract patch for mild to moderate acne in 26 women aged 15–45. Each participant applies the patch to one side of the face after using a standard tretinoin cream, while the other side gets only the cream. Researchers count acne lesions and check skin bacteria and inflammation before and after 21 days of treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- ginger (Zingiber officinale) extract patch
- What this could lead to
- If it works, this could offer a natural, topical option to reduce acne lesions with fewer side effects than standard treatments.
- What could go wrong
- This is a small, early-phase study with only 26 participants. The effect may be modest or not better than existing treatments, and results may not apply to everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2/3
Runs two stages together: whether the treatment works, then large-scale confirmation.
- Participants
-
About 26 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2024
- Expected to finish
-
Oct 2025
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
15 to 45 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * female * 15-45 years old * mild to moderate acne vulgaris according to Lehmann criteria * minimal 3 pustules on face that are distributed on right and left sides Exclusion Criteria: * history of allergy to ingredients that is used in research * history of topical acne medication and steroid in the last 2 weeks * history of medical aesthetic procedure such as laser and chemical peeling in the last 2 weeks * history of oral antibiotic therapy in the last 6 weeks * history of oral isotretinoin therapy in the last 6 months * history of probiotic consumption in the last 3 weeks * pregnancy and lactation
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acne vulgaris are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Doctoral Programme, Faculty of Medicine, Hasanuddin University
Makassar, South Sulawesi, Indonesia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Acne may signal hidden hormonal disorder in young women
- Hormone tests may reveal who benefits most from acne drug
- Blood pressure drug takes on antibiotics for Women's acne
- Can radiofrequency waves outperform acne gels?
- Can adding a chemical peel to microneedling erase acne scars better?
- Can a beam of light boost acne treatment?